Social Media Influencers Fueling Unofficial Trade for Unapproved Weight-Loss Drug
An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Express Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in individuals injecting products of uncertain source.
Several professionals stated the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has taken down violative content and banned related hashtags and query recommendations. The organization said it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.
Digital Trading Activities
Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
After moments of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.
Product Details and Pricing
Within these communities, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially serious health risks”.
